Skip to main content

Restricting HIV-1 infection

Sep. 1, 2017, 8:00 AM

The HIV-1 capsid protein (CA) interacts with viral factors that support infection and host factors that restrict it. The host protein cyclophilin A (CypA) binds to CA and enhances the action of host restriction factors that block HIV-1 infection.

Christopher Aiken, Ph.D., and colleagues investigated how CypA potentiates the action of the restriction factor TRIM5alpha in African green monkey cells. They did not find evidence of a role for CypA in promoting binding of TRIM5alpha to the viral capsid or inhibiting reverse transcription of the viral genome.

Instead, the investigators observed a CypA-dependent reduction in the accumulation of nuclear HIV-1 DNA, suggesting that CypA promotes TRIM5alpha inhibition of HIV-1 nuclear import. They reported their findings in the journal PLOS ONE.

The authors propose that CypA uses a common mechanism involving interactions of the virus with nuclear pore components to potentiate restriction of HIV-1 infection by TRIM5alpha and other capsid-targeting inhibitors.

This research was supported by National Institutes of Health grant AI076121.

Send suggestions for articles to highlight in Aliquots and any other feedback about the column to aliquots@vanderbilt.edu

Recent Stories from VUMC News and Communications Publications

Brighter days ahead

Vanderbilt Medicine

Brighter days ahead

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

Combating cancer disparities is an out-of-office assignment

Momentum

Combating cancer disparities is an out-of-office assignment

more